Chronic News and Research

RSS

Researchers present definitive explanation of how fibrotic cells destroy human liver

In the latest of a series of related papers, researchers at the University of California, San Diego School of Medicine, with colleagues in Austria and elsewhere, present a new and more definitive explanation of how fibrotic cells form, multiply and eventually destroy the human liver, resulting in cirrhosis. In doing so, the findings upend the standing of a long-presumed marker for multiple fibrotic diseases and reveal the existence of a previously unknown kind of inflammatory white blood cell.

21 Dec 2010

Pennsylvania's Medicaid program error rate less than half the national average, feds say

A new federal report finds Pennsylvania's Medicaid program has an error rate that is less than half the national average and well below estimates claimed in state-level audits, Governor Edward G. Rendell announced today.

21 Dec 2010

New research sheds light on complex regulatory pathways for effective innate immune system

New research by scientists at the University of California, San Diego School of Medicine and Skaggs School of Pharmacy and Pharmaceutical Sciences reveals that the immune system has an effective backup plan to protect the body from infection when the "master regulator" of the body's innate immune system fails.

21 Dec 2010

Biomet Biologics completes enrollment in Recover Kit clinical trial for chronic tennis elbow

Biomet, Inc., a global leader in the manufacture of orthopedic and biotechnology products, announced today that its subsidiary, Biomet Biologics, LLC, has completed the required 230 subject enrollment for its Recover® Kit clinical trial. This clinical trial studies the use of the Recover® Kit device, which produces autologous platelet-rich plasma (PRP) to treat chronic tennis elbow (lateral epicondylitis).

21 Dec 2010

'CART' treatment better than traditional cognitive therapy at altering hyperventilation and panic symptoms

A new treatment program teaches people who suffer from panic disorder how to reduce the terrorizing symptoms by normalizing their breathing.

21 Dec 2010

Study reveals nasal congestion can be a sign of severe asthma

Nasal congestion can be a sign of severe asthma, which means that healthcare professionals should be extra vigilant when it comes to nasal complaints. Furthermore, more severe asthma appears to be more common than previously thought, reveals a study from the Sahlgrenska Academy's Krefting Research Centre.

21 Dec 2010

Hemispherx to manufacture and supply Alferon N Injection to GP Pharm in Argentina

Hemispherx Biopharma, Inc. announced that the Company has entered into an agreement with GP Pharm Latinoamerica, an affiliate company of Spanish GP Pharm SA for the marketing of Alferon N Injection®, the Company's natural interferon injection product which has been FDA approved for a category of sexually transmitted diseases in Argentina with an option for other Latin American countries upon receipt of those respective countries' regulatory approval for any use of the product.

21 Dec 2010

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

VistaGen Therapeutics, Inc., a stem cell technology company focused on drug discovery and development, today announced the successful completion of its initial Phase 1 safety study of AV-101, the Company's novel orally available prodrug candidate for treatment of neuropathic pain. Neuropathic pain, a serious and chronic condition causing pain after an injury or disease of the peripheral or central nervous system, affects approximately 1.8 million people in the U.S.

20 Dec 2010

Lilly completes acquisition of Avid

Eli Lilly and Company today announced that it has completed the acquisition of Avid Radiopharmaceuticals, Inc., a privately held company developing novel molecular imaging compounds intended for the detection and monitoring of chronic human diseases. The transaction, first announced on November 8, 2010, has received the approval of Avid stockholders and clearance under the Hart-Scott-Rodino Antitrust Improvements Act. All other closing conditions have also been met.

20 Dec 2010

Idera reports positive data from IMO-2125/ribavirin combination Phase 1 trial in null-responder HCV patients

Idera Pharmaceuticals, Inc. announced today preliminary data from a 4-week dose-ranging Phase 1 clinical trial of IMO-2125 in combination with ribavirin in 60 treatment-naïve patients with genotype 1 chronic hepatitis C virus (HCV) infection. In the trial, treatment with IMO-2125 in combination with ribavirin was well tolerated and achieved substantial decline in virus levels at two days after the first dose of IMO-2125 and after four weeks of treatment.

20 Dec 2010

Exciting progress made in MS research during 2010

Exciting advances were made in 2010 in virtually every field of MS research. Progress toward finding new therapies for MS is illustrated by the availability of the first oral disease-modifying therapy for MS. Progress was also made toward finding ways to restore function and improving quality of life and specific MS symptoms through exercise, meditation, rehabilitation and medications, including the first therapy specifically approved to treat a symptom of MS (Ampyra).

20 Dec 2010

Chelsea completes successful NORTHERA pre-NDA assessment with FDA

Chelsea Therapeutics International, Ltd. announced it has completed a pre-NDA assessment with the U.S. Food and Drug Administration (FDA) and intends to accelerate its new drug application (NDA) for NORTHERA™(droxidopa) for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH), a chronic and potentially debilitating drop in blood pressure upon standing commonly associated Parkinson's disease, multiple system atrophy and pure autonomic failure.

20 Dec 2010

Health Care at Home: Trends and issues

Leaders in the nation's Health Care at Home movement outlined trends and issues during a webinar for physicians across the country today. The webinar, "Why Health Care is Going Home," offered industry insights and detailed the reasons why home care will play a major role in the future of health care in America.

20 Dec 2010

Take charge of your medical tests

Whether you're healthy or ill, there are a variety of medical tests your health care team might recommend for you. A yearly checkup often includes routine tests such as blood sugar and cholesterol levels, vision and hearing assessments, tests for heart functioning and others used to monitor a chronic condition—such as a lung function test for those with asthma.

20 Dec 2010

FVCG invests $175,000 in Celvive for stem cell research in spinal cord injury

Spinal cord injury (SCI) is a devastating neurological condition with limited therapeutic options. In the United States alone, there are more than 250,000 people living with SCI; approximately three million worldwide are affected.

20 Dec 2010

Research roundup: Gender differences in health spending; How the states could fare under the new law; Increased Medicare premiums

Health Affairs: Pronounced Gender And Age Differences Are Evident In Personal Health Care Spending Per Person - This paper examines health care spending by men and women in 2004, including comparisons "by age group, goods and services consumed, and payers, and an analysis of some of the most frequently cited health conditions and treatments associated with that spending."

20 Dec 2010

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

MDI announced today that it has added McKesson's CareEnhance® Disease Monitor software to the Viewpoint Analytics solutions portfolio. Integrating one of the industry's leading disease management products increases the breadth of solutions available from Viewpoint Analytics.

20 Dec 2010

Chronic News and Research

Researchers present definitive explanation of how fibrotic cells destroy human liver

Pennsylvania's Medicaid program error rate less than half the national average, feds say

New research sheds light on complex regulatory pathways for effective innate immune system

Biomet Biologics completes enrollment in Recover Kit clinical trial for chronic tennis elbow

'CART' treatment better than traditional cognitive therapy at altering hyperventilation and panic symptoms

Study reveals nasal congestion can be a sign of severe asthma

Hemispherx to manufacture and supply Alferon N Injection to GP Pharm in Argentina

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

Lilly completes acquisition of Avid

Idera reports positive data from IMO-2125/ribavirin combination Phase 1 trial in null-responder HCV patients

Exciting progress made in MS research during 2010

Chelsea completes successful NORTHERA pre-NDA assessment with FDA

Health Care at Home: Trends and issues

Take charge of your medical tests

FVCG invests $175,000 in Celvive for stem cell research in spinal cord injury

Research roundup: Gender differences in health spending; How the states could fare under the new law; Increased Medicare premiums

MDI adds McKesson's CareEnhance Disease Monitor software to Viewpoint Analytics solutions portfolio

Researchers examine socio-economic consequences of hypersomnia

Study finds second skin barrier structure may play a role in eczema development

SAGE publishes first comprehensive textbook on psychology

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News